Clinical Trial Update: TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma [NA]

View source ↗

Summary

This clinical trial protocol compares tenofovir alafenamide (TAF) monotherapy to entecavir (ETV) plus TAF for hepatitis B-related hepatocellular carcinoma to as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• Baraclude (entecavir)
• Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatitis B, Hepatocellular Carcinoma (HCC) | NA | Status: NOT_YET_RECRUITING